1
|
Velay A, Baquer F, Brunet J, Denis J, Parfut A, Talagrand-Reboul E, Hansmann Y. Infectious risks associated with outdoor sports activities. Infect Dis Now 2024; 54:104862. [PMID: 38845331 DOI: 10.1016/j.idnow.2024.104862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2024] [Accepted: 02/02/2024] [Indexed: 06/15/2024]
Abstract
In France, outdoor sports and activities account for 36% of sports engagement, making outdoor venues the most popular settings for sports participation. Discussing the links between sports and health almost always highlights the beneficial impact of engaging in sports. However, due to a lack of specific notifications, infectious risks are not subject to epidemiological monitoring, and need to be better understood. Since the practice of outdoor sports has become part and parcel of many individuals' daily routines, it is essential to more accurately characterize the knowledge we have gained about the risks associated with exposure. However, directly associating the practice of a sport with an elevated risk of infectious diseases is a challenging endeavor. Sociological factors based on risk awareness and adoption of protective behaviors in response to the risk are crucial to the orientation of prevention efforts. This review deals with several (bacteriological, viral, parasitic, and mycological) infectious risks related to outdoor activities practiced in a natural field via contamination routes such as tick-bite, enteric pathogen, skin, and aerosol transmission. We have also detailed a number of preventive measures taking into account the outdoor setting (e.g., vaccination).
Collapse
Affiliation(s)
- Aurélie Velay
- Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
| | - Florian Baquer
- Laboratoire de Bactériologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | - Julie Brunet
- Laboratoire de Parasitologie et Mycologie Médicale, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | - Julie Denis
- Laboratoire de Parasitologie et Mycologie Médicale, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | - Assilina Parfut
- Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | | | - Yves Hansmann
- Service des Maladies Infectieuses et Tropicales, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| |
Collapse
|
2
|
Raji Y, Knapik DM, Schroeder AN, Voos JE. Common Sports Infectious Disease. HSS J 2023; 19:351-357. [PMID: 37435124 PMCID: PMC10331262 DOI: 10.1177/15563316221149025] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/10/2022] [Accepted: 10/07/2022] [Indexed: 08/03/2024]
Abstract
There is growing concern about the impact of infectious diseases in athletes, especially as they relate to exposures in athletic training facilities. This article reviews common pathogens encountered in athletic training facilities, while offering an evidence-based overview of practical preventative measures that can be implemented to reduce the incidence of infectious diseases in close-contact sports such as American football and wrestling.
Collapse
Affiliation(s)
- Yazdan Raji
- Department of Orthopaedic Surgery, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
| | - Derrick M Knapik
- Department of Orthopedic Surgery, Washington University in St. Louis, St. Louis, MO, USA
| | - Allison N Schroeder
- Department of Orthopaedic Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
- Sports Medicine Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
- Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - James E Voos
- Department of Orthopaedic Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
- Sports Medicine Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
- Case Western Reserve University School of Medicine, Cleveland, OH, USA
| |
Collapse
|
3
|
Komici K, Verderosa S, D’Amico F, Guerra G. Self-reported side effects following COVID-19 vaccination in athletes: A retrospective study. Hum Vaccin Immunother 2023; 19:2234788. [PMID: 37470390 PMCID: PMC10361131 DOI: 10.1080/21645515.2023.2234788] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 06/19/2023] [Accepted: 07/06/2023] [Indexed: 07/21/2023] Open
Abstract
Billions of coronavirus disease 19 (COVID-19) vaccines have been administered worldwide. However, limited data on side effects have been reported in athletes. This study aimed to describe the incidence of side effects following COVID-19 vaccination in athletes and to identify the factors associated with the main side effects in this population. Information on COVID-19 vaccination, side effects, and overall symptom duration was retrospectively collected from recreational and competitive athletes. A total of 460 participants were included in this study. Fever and arm pain were more frequently reported after the first-dose vaccination, 9.6% vs 4.6%, p = .007 and 81.3% vs 24.9%, p ≤ .001. Myalgia was more common after the second-dose vaccination, 0.65% vs. 7.1% p ≤ .001. Males were more likely to present with arm pain after the first and second vaccinations. Those with SARS-CoV-2 infection before vaccination were less likely to present with arm pain after the first dose of vaccination (OR: 0.162, p ≤ .001) and more likely to present with fever after the second dose of vaccination (OR: 3.442, p = .046). First-dose vaccination with the BNT162b2 vaccine compared to other brands was characterized by lower odds of fever (OR: 0.394, p = .017). Our results indicated mild adverse effects and a short duration of symptoms in athletes following COVID-19 vaccination.
Collapse
Affiliation(s)
- Klara Komici
- Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy
| | - Sofia Verderosa
- Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy
| | - Fabio D’Amico
- Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy
| | - Germano Guerra
- Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy
| |
Collapse
|
4
|
Miljoen H, Bekhuis Y, Roeykens J, Taha K, Frankinouille R, Michielsen M, Van de Heyning CM, Cornelissen V, Favere K, Eens S, Gielen J, Goetschalckx K, Heidbuchel H, Claessen G. Effect of BNT162b2 mRNA booster vaccination on VO
2
max
in recreational athletes: A prospective cohort study. Health Sci Rep 2022; 5:e929. [PMCID: PMC9679380 DOI: 10.1002/hsr2.929] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2022] [Revised: 09/27/2022] [Accepted: 10/24/2022] [Indexed: 11/24/2022] Open
Affiliation(s)
- Hielko Miljoen
- Department of Cardiology Antwerp University Hospital Antwerp Belgium
- Department of Medicine and Health Sciences University of Antwerp Antwerp Belgium
| | - Youri Bekhuis
- Department of Cardiovascular Sciences Cardiology, KU Leuven Leuven Belgium
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
- Faculty of Medicine and Life Sciences, Cardiology and Organ Systems University of Hasselt Hasselt Belgium
| | - Johan Roeykens
- Department of Cardiology Antwerp University Hospital Antwerp Belgium
- Department of Medicine and Health Sciences University of Antwerp Antwerp Belgium
| | - Karim Taha
- Department of Cardiovascular Sciences Cardiology, KU Leuven Leuven Belgium
- Department of Cardiology University Medical Center Utrecht Utrecht The Netherlands
| | - Rudi Frankinouille
- Department of Cardiology Antwerp University Hospital Antwerp Belgium
- Department of Medicine and Health Sciences University of Antwerp Antwerp Belgium
| | - Matthijs Michielsen
- Department of Rehabilitation Sciences, Group Rehabilitation in Internal Disorders KU Leuven Leuven Belgium
| | - Caroline M. Van de Heyning
- Department of Cardiology Antwerp University Hospital Antwerp Belgium
- Department of Medicine and Health Sciences University of Antwerp Antwerp Belgium
| | - Véronique Cornelissen
- Department of Rehabilitation Sciences, Group Rehabilitation in Internal Disorders KU Leuven Leuven Belgium
| | - Kasper Favere
- Department of Medicine and Health Sciences University of Antwerp Antwerp Belgium
- Department of Internal Medicine Ghent University Ghent Belgium
| | - Sander Eens
- Department of Medicine and Health Sciences University of Antwerp Antwerp Belgium
| | - Jan Gielen
- Department of Medicine and Health Sciences University of Antwerp Antwerp Belgium
- Department of Radiology Antwerp University Hospital Antwerp Belgium
| | - Kaatje Goetschalckx
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
| | - Hein Heidbuchel
- Department of Cardiology Antwerp University Hospital Antwerp Belgium
- Department of Medicine and Health Sciences University of Antwerp Antwerp Belgium
- Faculty of Medicine and Life Sciences, Cardiology and Organ Systems University of Hasselt Hasselt Belgium
| | - Guido Claessen
- Department of Cardiovascular Sciences Cardiology, KU Leuven Leuven Belgium
- Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
| | | |
Collapse
|
5
|
Sobierajski T, Krzywański J, Mikulski T, Pokrywka A, Krysztofiak H, Kuchar E. Sports Elite Means Vaccine Elite? Concerns and Beliefs Related to COVID-19 Vaccines among Olympians and Elite Athletes. Vaccines (Basel) 2022; 10:vaccines10101676. [PMID: 36298541 PMCID: PMC9607255 DOI: 10.3390/vaccines10101676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Revised: 09/23/2022] [Accepted: 09/30/2022] [Indexed: 11/30/2022] Open
Abstract
(1) Background: The purpose of this study was to investigate the concerns and beliefs of Olympians and elite athletes toward COVID-19 vaccination. (2) Methods: The study was framed by a quantitative method and was conducted using the PAPI (pen and paper interview) technique among 895 Polish elite athletes representing 34 sports. (3) Results: Three-quarters (76.3%) of the athletes were vaccinated against COVID-19; statistically participants were more likely to be women, and athletes who participated in the Olympic Games. Four in ten (39.2%) were in favor of vaccination. Athletes were mainly concerned that COVID-19 would exclude them from training/competition (19.3%) and could have a long-term impact on their health (17.2%). Athletes who were vaccinated reported much higher confidence in the composition of the vaccine and the doctors who recommended vaccination than unvaccinated athletes. Athletes who competed at the Olympic level were more likely than others to disbelieve that vaccines were produced too quickly and were not well tested. National-level athletes showed the highest degree of distrust in the government regarding COVID-19 vaccination, with one in six respondents distrusting doctors with respect to COVID-19 vaccination. Four in ten respondents said they were in favor of vaccination. (4) Conclusions: Athletes' attitudes toward COVID-19 vaccination were significantly influenced by their environment-especially coaches and relatives. The power of social norms with respect to the decision to vaccinate against COVID-19 was very strong. Therefore, it is essential to build awareness about preventive policies among athletes and their social environment.
Collapse
Affiliation(s)
- Tomasz Sobierajski
- Faculty of Applied Social Sciences and Resocialization, University of Warsaw, 26/28 Krakowskie Przedmieście Str., 00-927 Warsaw, Poland
- Correspondence: ; Tel.: +48-503-456-234
| | - Jarosław Krzywański
- National Centre for Sports Medicine, 63A Żwirki i Wigury Str., 02-091 Warszawa, Poland
| | - Tomasz Mikulski
- Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warszawa, Poland
| | - Andrzej Pokrywka
- Department of Biochemistry and Pharmacogenomics, Medical University of Warsaw, 1 Banacha Str., 02-097 Warszawa, Poland
| | - Hubert Krysztofiak
- National Centre for Sports Medicine, 63A Żwirki i Wigury Str., 02-091 Warszawa, Poland
- Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warszawa, Poland
| | - Ernest Kuchar
- Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, 63A Żwirki i Wigury Str., 02-091 Warszawa, Poland
| |
Collapse
|
6
|
Schwellnus M, Adami PE, Bougault V, Budgett R, Clemm HH, Derman W, Erdener U, Fitch K, Hull JH, McIntosh C, Meyer T, Pedersen L, Pyne DB, Reier-Nilsen T, Schobersberger W, Schumacher YO, Sewry N, Soligard T, Valtonen M, Webborn N, Engebretsen L. International Olympic Committee (IOC) consensus statement on acute respiratory illness in athletes part 1: acute respiratory infections. Br J Sports Med 2022; 56:bjsports-2022-105759. [PMID: 35863871 DOI: 10.1136/bjsports-2022-105759] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/04/2022] [Indexed: 11/04/2022]
Abstract
Acute illnesses affecting the respiratory tract are common and form a significant component of the work of Sport and Exercise Medicine (SEM) clinicians. Acute respiratory illness (ARill) can broadly be classified as non-infective ARill and acute respiratory infections (ARinf). The aim of this consensus is to provide the SEM clinician with an overview and practical clinical approach to ARinf in athletes. The International Olympic Committee (IOC) Medical and Scientific Commission appointed an international consensus group to review ARill (non-infective ARill and ARinf) in athletes. Six subgroups of the IOC Consensus group were initially established to review the following key areas of ARill in athletes: (1) epidemiology/risk factors for ARill, (2) ARinf, (3) non-infective ARill including ARill due to environmental exposure, (4) acute asthma and related conditions, (5) effects of ARill on exercise/sports performance, medical complications/return-to-sport and (6) acute nasal/vocal cord dysfunction presenting as ARill. Several systematic and narrative reviews were conducted by IOC consensus subgroups, and these then formed the basis of sections in the consensus documents. Drafting and internal review of sections were allocated to 'core' members of the consensus group, and an advanced draft of the consensus document was discussed during a meeting of the main consensus core group in Lausanne, Switzerland on 11 to 12 October 2021. Final edits were completed after the meeting. This consensus document (part 1) focusses on ARinf, which accounts for the majority of ARill in athletes. The first section of this consensus proposes a set of definitions and classifications of ARinf in athletes to standardise future data collection and reporting. The remainder of the consensus paper examines a wide range of clinical considerations related to ARinf in athletes: epidemiology, risk factors, pathology/pathophysiology, clinical presentation and diagnosis, management, prevention, medical considerations, risks of infection during exercise, effects of infection on exercise/sports performance and return-to-sport guidelines.
Collapse
Affiliation(s)
- Martin Schwellnus
- Sport, Exercise Medicine and Lifestyle Institute (SEMLI), Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
- International Olympic Committee Research Centre, Pretoria, South Africa
| | - Paolo Emilio Adami
- Health and Science Department, World Athletics, Monaco, Monaco Principality
| | - Valerie Bougault
- Laboratoire Motricité Humaine Expertise Sport Santé, Université Côte d'Azur, Nice, France
| | - Richard Budgett
- Medical and Scientific Department, International Olympic Committee, Lausanne, Switzerland
| | - Hege Havstad Clemm
- Department of Pediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway
- Department of Clinical Science, University of Bergen, Bergen, Norway
| | - Wayne Derman
- International Olympic Committee Research Centre, Pretoria, South Africa
- Institute of Sport and Exercise Medicine (ISEM), Department of Sport Science, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa
| | - Uğur Erdener
- Medical and Scientific Department, International Olympic Committee, Lausanne, Switzerland
| | - Ken Fitch
- School of Human Science; Sports, Exercise and Health, University of Western Australia, Perth, Western Australia, Australia
| | - James H Hull
- Department of Respiratory Medicine, Royal Brompton Hospital, London, UK
- Institute of Sport, Exercise and Health (ISEH), University College London (UCL), London, UK
| | | | - Tim Meyer
- Institute of Sports and Preventive Medicine, Saarland University, Saarbrucken, Germany
| | - Lars Pedersen
- Department of Respiratory Medicine, Bispebjerg Hospital, Copenhagen, Denmark
| | - David B Pyne
- Research Institute for Sport and Exercise, University of Canberra, Canberra, Australian Capital Territory, Australia
| | - Tonje Reier-Nilsen
- The Norwegian Olympic Sports Centre, Oslo, Norway
- Trauma Research Center, Department of Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway
| | - Wolfgang Schobersberger
- Institute for Sports Medicine, Alpine Medicine & Health Tourism (ISAG), University Hospital - Tirol Kliniken Innsbruck and Private University UMIT Tirol, Hall, Austria
| | | | - Nicola Sewry
- Sport, Exercise Medicine and Lifestyle Institute (SEMLI), Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
- International Olympic Committee Research Centre, Pretoria, South Africa
| | - Torbjørn Soligard
- Medical and Scientific Department, International Olympic Committee, Lausanne, Switzerland
| | | | - Nick Webborn
- Centre for Sport and Exercise Science and Medicine, University of Brighton, Brighton, UK
| | - Lars Engebretsen
- Medical and Scientific Department, International Olympic Committee, Lausanne, Switzerland
- Trauma Research Center, Department of Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway
| |
Collapse
|
7
|
Agha-Alinejad H, Ahmadi Hekmatikar AH, Ruhee RT, Shamsi MM, Rahmati M, Khoramipour K, Suzuki K. A Guide to Different Intensities of Exercise, Vaccination, and Sports Nutrition in the Course of Preparing Elite Athletes for the Management of Upper Respiratory Infections during the COVID-19 Pandemic: A Narrative Review. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19031888. [PMID: 35162910 PMCID: PMC8835175 DOI: 10.3390/ijerph19031888] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/07/2021] [Revised: 01/27/2022] [Accepted: 02/03/2022] [Indexed: 02/07/2023]
Abstract
Elite athletes use high-intensity training to maintain their fitness level. However, intense training can harm the immune system, making athletes suspectable to COVID-19 and negatively affecting their performance. In addition, the diet of athletes should be appreciated more as it is another influencer of the immune system, especially during the COVID 19 pandemic. The other important issue elite athletes face currently is vaccination and its possible intervention with their training. The present study attempts to discuss the impact of different training intensities, nutritional strategies, and vaccination on the immune system function in elite athletes. To this end, Scopus, ISC, PubMed, Web of Science, and Google Scholar databases were searched from 1988 to 2021 using the related keywords. The results of our review showed that although high-intensity exercise can suppress the immune system, elite athletes should not stop training in the time of infection but use low- and moderate-intensity training. Moderate-intensity exercise can improve immune function and maintain physical fitness. In addition, it is also better for athletes not to undertake high-intensity training at the time of vaccination, but instead perform moderate to low-intensity training. Furthermore, nutritional strategies can be employed to improve immune function during high-intensity training periods.
Collapse
Affiliation(s)
- Hamid Agha-Alinejad
- Department of Physical Education and Sport Sciences, Faculty of Humanities, Tarbiat Modares University, Teheran 1411713116, Iran; (H.A.-A.); (A.H.A.H.); (M.M.S.)
| | - Amir Hossein Ahmadi Hekmatikar
- Department of Physical Education and Sport Sciences, Faculty of Humanities, Tarbiat Modares University, Teheran 1411713116, Iran; (H.A.-A.); (A.H.A.H.); (M.M.S.)
| | | | - Mahdieh Molanouri Shamsi
- Department of Physical Education and Sport Sciences, Faculty of Humanities, Tarbiat Modares University, Teheran 1411713116, Iran; (H.A.-A.); (A.H.A.H.); (M.M.S.)
| | - Masoud Rahmati
- Department of Physical Education and Sport Sciences, Faculty of Literature and Human Sciences, Lorestan University, Khoramabad 6816785468, Iran;
| | - Kayvan Khoramipour
- Institute of Neuropharmacology, Neuroscience Research Center, Department of Physiology and Pharmacology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman 7616914115, Iran
- Student Research Committee, Kerman University of Medical Sciences, Kerman 7619813159, Iran
- Correspondence: or (K.K.); (K.S.); Tel.: +98-9120356383 (K.K.); +81-4-2947-6898 (K.S.)
| | - Katsuhiko Suzuki
- Faculty of Sport Sciences, Waseda University, Tokorozawa 359-1192, Japan
- Correspondence: or (K.K.); (K.S.); Tel.: +98-9120356383 (K.K.); +81-4-2947-6898 (K.S.)
| |
Collapse
|
8
|
Batatinha H, Baker FL, Smith KA, Zúñiga TM, Pedlar CR, Burgess SC, Katsanis E, Simpson RJ. Recent COVID-19 vaccination has minimal effects on the physiological responses to graded exercise in physically active healthy people. J Appl Physiol (1985) 2022; 132:275-282. [PMID: 34882029 PMCID: PMC8799387 DOI: 10.1152/japplphysiol.00629.2021] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2021] [Revised: 12/06/2021] [Accepted: 12/06/2021] [Indexed: 12/16/2022] Open
Abstract
Athletes are advised to receive the COVID-19 vaccination to protect themselves from SARS-CoV-2 infection during major competitions. Despite this, many athletes are reluctant to get the COVID-19 vaccine due to concerns that symptoms of vaccinosis may impair athletic performance. This study aimed to determine the effects of COVID-19 vaccination on the physiological responses to graded exercise. Healthy physically active participants completed a 20-min bout of graded cycling exercise at intensities corresponding to 50%, 60%, 70%, and 80% of the predetermined V̇O2max before and ∼21 days after receiving the COVID-19 vaccine (2-dose Pfizer mRNA or 1-dose Johnson & Johnson). Vaccination had no effect on a large number of physiological responses to exercise measured in blood (e.g., lactate, epinephrine, and cortisol) and by respiratory gas exchange (e.g., oxygen uptake, CO2 production, ventilation, respiratory exchange ratio, predicted V̇O2max, and ventilatory threshold) (P > 0.05). We did, however, find significant elevations in heart rate (∼5 beats/min) and norepinephrine (P = 0.006 and 0.04, respectively) in response to vigorous (i.e., 70%-80% V̇O2max) intensity exercise after vaccination, particularly in those who received the two-shot Pfizer mRNA vaccine regimen. These findings held true when compared with demographically matched controls who completed identical bouts of exercise several weeks apart without receiving a vaccine; delta values for heart rate (P = 0.03) and norepinephrine (P = 0.01) were elevated in the second trial for those who received the Pfizer mRNA vaccine compared with the controls at the 70% and 80% V̇O2max stages, respectively. Recent COVID-19 vaccination has minimal effects on the physiological responses to graded exercise in physically active healthy people. The small elevations in cardiovascular and neuroendocrine responses to exercise after the Pfizer mRNA vaccine regimen could have implications for athletes at the elite level and warrants investigation.NEW & NOTEWORTHY Recent COVID-19 vaccination does not affect a large number of physiological responses to graded exercise, indicating that vaccination is unlikely to impair exercise capacity in normal healthy people. Heart rate and norepinephrine levels were elevated in response to exercise after the two-dose Pfizer mRNA vaccination compared to controls. Small elevations in cardiovascular and neuroendocrine responses to exercise after recent COVID-19 vaccination could have implications for exercise performance in elite athletes and warrants investigation.
Collapse
Affiliation(s)
- Helena Batatinha
- School of Nutritional Sciences and Wellness, University of Arizona, Tucson, Arizona
| | - Forrest L Baker
- School of Nutritional Sciences and Wellness, University of Arizona, Tucson, Arizona
- Department of Pediatrics, University of Arizona, Tucson, Arizona
| | - Kyle A Smith
- School of Nutritional Sciences and Wellness, University of Arizona, Tucson, Arizona
| | - Tiffany M Zúñiga
- School of Nutritional Sciences and Wellness, University of Arizona, Tucson, Arizona
| | - Charles R Pedlar
- Faculty of Sport, Allied Health and Performance Science, St. Mary's University, London, United Kingdom
- Institute of Sport Exercise and Health, University College London, London, United Kingdom
| | - Shane C Burgess
- Department of Animal and Comparative Biomedical Sciences, University of Arizona, Tucson, Arizona
- The University of Arizona Cancer Center, Tucson, Arizona
| | - Emmanuel Katsanis
- Department of Pediatrics, University of Arizona, Tucson, Arizona
- The University of Arizona Cancer Center, Tucson, Arizona
- Department of Immunobiology, University of Arizona, Tucson, Arizona
- Department of Medicine, University of Arizona, Tucson, Arizona
- Department of Pathology, University of Arizona, Tucson, Arizona
| | - Richard J Simpson
- School of Nutritional Sciences and Wellness, University of Arizona, Tucson, Arizona
- Department of Pediatrics, University of Arizona, Tucson, Arizona
- The University of Arizona Cancer Center, Tucson, Arizona
- Department of Immunobiology, University of Arizona, Tucson, Arizona
| |
Collapse
|
9
|
Hull JH, Wootten M, Ranson C. Tolerability and impact of SARS-CoV-2 vaccination in elite athletes. THE LANCET RESPIRATORY MEDICINE 2022; 10:e5-e6. [PMID: 34902331 PMCID: PMC8664388 DOI: 10.1016/s2213-2600(21)00548-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/12/2021] [Revised: 11/19/2021] [Accepted: 11/21/2021] [Indexed: 01/07/2023]
|
10
|
Krzywański J, Kuchar E, Pokrywka A, Mikulski T, Pilchowska I, Młyńczak M, Krysztofiak H, Jurczyk J, Ziemba A, Nitsch-Osuch A. Safety and Impact on Training of the Influenza Vaccines in Elite Athletes Participating in the Rio 2016 Olympics. Clin J Sport Med 2021; 31:423-429. [PMID: 32032168 DOI: 10.1097/jsm.0000000000000808] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/21/2019] [Accepted: 09/27/2019] [Indexed: 02/02/2023]
Abstract
OBJECTIVE The aim of the study was to evaluate the safety and tolerance of influenza vaccines for the northern and southern hemispheres in Polish elite athletes participating in the Rio 2016 Olympics. DESIGN Prospective, observational, cohort study. SETTING Institutional level. PARTICIPANTS Ninety-seven athletes vaccinated only with the northern hemisphere vaccine; 98 athletes received the southern hemisphere vaccine alone, whereas 39 athletes were vaccinated with both vaccines. INTERVENTIONS The athletes were vaccinated with a trivalent, inactivated influenza vaccine recommended for the northern hemisphere 2015/2016 and then with the vaccine recommended for the southern hemisphere 2016. Athletes kept a diary of adverse events and effects (if any) on training for 6 days after vaccination. MAIN OUTCOME MEASURES The percentage of general and local adverse events, number of lost or modified training sessions. RESULTS Significantly more local adverse events (pain and redness) were found in the group immunized with the vaccine for the northern hemisphere. There were no differences in the frequency of general adverse events and influence on training between groups. Of total 273 athletes who had 1911 training days during 6 days after vaccination, 6 athletes (2.2%) lost 13 training days (0.7%) and 16 athletes (5.9%) had to modify 34 (1.7%) training days within first 2 days after vaccination. CONCLUSIONS Athletes tolerated influenza immunization well. If they are going to travel to the other hemisphere during the influenza season, the use of the second influenza vaccine should be advised. Athletes should anticipate modification of trainings for 2 days after vaccination.
Collapse
Affiliation(s)
| | - Ernest Kuchar
- Department of Pediatrics with Medical Assessment Unit, Medical University of Warsaw, Warsaw, Poland
| | - Andrzej Pokrywka
- National Centre for Sports Medicine, Warsaw, Poland
- Department of Applied and Clinical Physiology, University of Zielona Gora, Zielona Gora, Poland
| | - Tomasz Mikulski
- Department of Applied Physiology, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland
| | - Iwona Pilchowska
- Department of Psychology, SWPS University of Social Sciences and Humanities, Warsaw, Poland
| | - Marcel Młyńczak
- Institute of Metrology and Biomedical Engineering, Warsaw University of Technology, Warsaw, Poland ; and
| | - Hubert Krysztofiak
- National Centre for Sports Medicine, Warsaw, Poland
- Department of Applied Physiology, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland
| | | | - Andrzej Ziemba
- Department of Applied Physiology, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland
| | - Aneta Nitsch-Osuch
- Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland
| |
Collapse
|
11
|
Conway JJ, Curriero FC, Camp CL, Toresdahl BG, Coleman S, Kinderknecht JJ. Time Out of Play Due to Illness in Major and Minor League Baseball. Clin J Sport Med 2021; 31:e137-e143. [PMID: 31219928 DOI: 10.1097/jsm.0000000000000756] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/10/2018] [Accepted: 04/09/2019] [Indexed: 02/02/2023]
Abstract
OBJECTIVE To generate a summative report on the most commonly diagnosed illnesses in Major League Baseball (MLB) and Minor League Baseball (MiLB) athletes with specific attention to their impact based on time out of play. DESIGN Retrospective analysis. SETTING Injury and illness data from the MLB Health and Injury Tracking System. PARTICIPANTS All MLB and MiLB athletes active between 2011 and 2016. ASSESSMENT OF RISK FACTORS Illnesses were defined as atraumatic medical diagnoses that occurred during the MLB or MiLB season and resulted in at least 1 day out of play. MAIN OUTCOME MEASURES Incidence of illness diagnoses and resulting time out play. RESULTS Eight thousand eight hundred thirty-four illnesses were reported, representing 14.7% of all diagnoses resulting in time out of play. Total days missed (DM) due to illness were 39 614, with a mean of 4.6 (SD 9.9 days) and median 2 DM per diagnosis. The annual incidence of illness per season was 20.3 per 100 athletes. The most common diagnosis was nonspecific viral illness (15.3%), followed by gastroenteritis (13.6%), other gastrointestinal illness (8.3%), influenza (7.0%), and upper respiratory infection (6.2%). Appendicitis (15.2%) and Epstein-Barr virus/cytomegalovirus (9.1%) were the most common season-ending diagnoses. CONCLUSIONS Illnesses represent a significant cause of time out of play in MLB and MiLB. Prevention efforts should focus on limiting the spread of communicable viral, respiratory, and gastrointestinal disease among players, as the majority of diagnoses fell into these categories. This work may be used to guide future research into illness treatment and prevention in professional baseball.
Collapse
Affiliation(s)
| | - Frank C Curriero
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
| | | | - Brett G Toresdahl
- Primary Care Sports Medicine Service, Hospital for Special Surgery, New York, New York; and
| | - Struan Coleman
- Sports Medicine and Shoulder Service, Hospital for Special Surgery, New York, New York
| | - James J Kinderknecht
- Primary Care Sports Medicine Service, Hospital for Special Surgery, New York, New York; and
| |
Collapse
|
12
|
Stenger T, Ledo A, Ziller C, Schub D, Schmidt T, Enders M, Gärtner BC, Sester M, Meyer T. Timing of Vaccination after Training: Immune Response and Side Effects in Athletes. Med Sci Sports Exerc 2020; 52:1603-1609. [PMID: 31977634 DOI: 10.1249/mss.0000000000002278] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
OBJECTIVES Influenza vaccination was used to assess whether induction of immunity or side effects are influenced by the timing of the last training session before vaccination. METHODS Forty-five healthy athletes (36 male, 23 ± 8 yr, ≥5 training sessions per week, predominantly national competition level) were vaccinated with the tetravalent influenza vaccine; blood samples were collected immediately before and 1, 2, and 26 wk after vaccination. Athletes were randomly assigned to vaccination within 2 h after the last training session versus after 24-26 h. Influenza-specific T cells were quantified after stimulation with the vaccine based on intracellular cytokine staining. Antibodies (IgA, IgG, IgM) were quantified by enzyme-linked immunosorbent assay and neutralization assay. Participants documented resulting side effects and training restrictions using a standardized diary. RESULTS Both groups showed an increase in influenza-reactive CD4 T-cell levels, which peaked 1 wk after vaccination (fold changes to baseline; median (interquartile range), 3.7 (3.0-5.4; P < 0.001) in the 2-h group; 4.6 (2.8-7.4; P < 0.001) in the 26-h group) with no difference between groups (P = 0.52). Influenza-specific antibodies showed a significant increase after vaccination in both groups (at least 1.4-fold, each P < 0.001, no group differences; P = 0.24-0.97 for different antibody types). Only antibodies toward the Brisbane strain showed a trend toward significant differences in neutralization titers between groups (4-fold (2-17.8) in the 2-h group, 16-fold (4-32.9) in the 26-h group; P = 0.06), whereas other specificities did not differ (P = 0.16-0.72). No intergroup differences were found for side effects; no athlete reported a loss of training time due to the vaccination or its side effects. CONCLUSION Infection prophylaxis in elite athletes by influenza vaccination seems to be effective and safe. Timing of vaccination after prior training does not seem to require specific constraints.
Collapse
Affiliation(s)
- Tanja Stenger
- Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, GERMANY
| | - Alexandra Ledo
- Department of Transplant and Infection Immunology, Saarland University, Homburg/Saar, GERMANY
| | - Clemens Ziller
- Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, GERMANY
| | - David Schub
- Department of Transplant and Infection Immunology, Saarland University, Homburg/Saar, GERMANY
| | - Tina Schmidt
- Department of Transplant and Infection Immunology, Saarland University, Homburg/Saar, GERMANY
| | - Martin Enders
- Laboratory Prof. G. Enders and Partners and Institute of Virology, Infectious Diseases and Epidemiology e.V., Stuttgart, GERMANY
| | - Barbara C Gärtner
- Institute of Medical Microbiology and Hygiene, Saarland University, Homburg/Saar, GERMANY
| | - Martina Sester
- Department of Transplant and Infection Immunology, Saarland University, Homburg/Saar, GERMANY
| | - Tim Meyer
- Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, GERMANY
| |
Collapse
|
13
|
O' Leary F, O' Donovan J. Attitudes of elite athletes and their support staff to the influenza vaccine. Ir J Med Sci 2020; 190:1231-1236. [PMID: 33111253 DOI: 10.1007/s11845-020-02408-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2020] [Accepted: 10/15/2020] [Indexed: 11/28/2022]
Abstract
BACKGROUND Influenza is an important public health issue, even amongst healthy adults. Uptake rates of the influenza vaccine amongst elite athletes vary and can depend on the attitudes of their coaches, fellow athletes and support staff. International studies have documented a fear amongst elite athletes to the potential side effects of the vaccine. AIMS Determine the influenza vaccine uptake rates in elite Irish athletes and their support staff along with attitudes, fears and barriers to receiving it. METHODS A cross-sectional survey was performed in the Sport Ireland Institute. Elite athletes and support staff from the 2019 database were invited to participate via an anonymous online survey. The database included a variety of sports, e.g. athletics, boxing, cycling, rowing, swimming and para-athletics. RESULTS From 218 athletes and staff invited, 39% (n = 87 [43 male, 44 female]) responded to the online survey. Fifty-nine percent (n = 51) of participants received the influenza vaccine during the 2018/2019 season. Forty-six percent (n = 40) completely agree that the influenza vaccine is safe. Fourteen percent (n = 12) of participants believe the vaccine causes influenza. "Getting sick" from the vaccine was the biggest fear for participants. Athletes were least likely to recommend the influenza vaccine to others and most likely to fear missing time from training or work as a result of it. CONCLUSIONS Elite Irish athletes are vulnerable to contracting influenza annually, despite free access to immunisation. Barriers to receiving the vaccine include location access, education and fear of side effects.
Collapse
Affiliation(s)
- Frank O' Leary
- Sport Ireland Institute, National Sports Campus, Abbotstown, Dublin 15, Ireland.
| | - James O' Donovan
- Sport Ireland Institute, National Sports Campus, Abbotstown, Dublin 15, Ireland
| |
Collapse
|
14
|
Entenfellner J, Gahan J, Garvey M, Walsh C, Venner M, Cullinane A. Response of Sport Horses to Different Formulations of Equine Influenza Vaccine. Vaccines (Basel) 2020; 8:vaccines8030372. [PMID: 32664411 PMCID: PMC7563521 DOI: 10.3390/vaccines8030372] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2020] [Revised: 07/02/2020] [Accepted: 07/07/2020] [Indexed: 01/28/2023] Open
Abstract
The international governing body of equestrian sports requires that horses be vaccinated against equine influenza within 6 months and 21 days of competing. The aim of this study was to compare the antibody response of young sport horses to six-monthly booster vaccination with equine influenza vaccines of different formulations. An inactivated vaccine was allocated to 35 horses and subunit and recombinant vaccines were allocated to 34 horses each. After vaccination, all horses were monitored for evidence of adverse reactions. Whole blood samples were collected at the time of vaccination and on nine occasions up to six months and 21 days post vaccination. Antibodies against equine influenza were measured by single radial haemolysis. Transient fever and injection site reactions were observed in several horses vaccinated with each vaccine. Only two horses failed to seroconvert post booster vaccination but there was a delayed response to the recombinant vaccine. The antibody response to the recombinant vaccine was lower than that induced by the whole-inactivated and subunit vaccines up to three months post vaccination. Thereafter, there was no significant difference. By six months post vaccination, the majority of horses in all three groups were clinically but not virologically protected. There was minimal decline in antibody titres within the 21-day grace period.
Collapse
Affiliation(s)
| | - Jacinta Gahan
- Irish Equine Centre, Johnstown, Naas, Co. Kildare, W91 RH93 Johnstown, Ireland; (J.G.); (M.G.)
| | - Marie Garvey
- Irish Equine Centre, Johnstown, Naas, Co. Kildare, W91 RH93 Johnstown, Ireland; (J.G.); (M.G.)
| | - Cathal Walsh
- Department of Mathematics and Statistics, University of Limerick, V94 T9PX Limerick, Ireland;
| | - Monica Venner
- Pferdeklinik Destedt GmbH, Destedt, Trift 4, 38162 Cremlingen, Germany;
| | - Ann Cullinane
- Irish Equine Centre, Johnstown, Naas, Co. Kildare, W91 RH93 Johnstown, Ireland; (J.G.); (M.G.)
- Correspondence: ; Tel.: +353-45-866-266
| |
Collapse
|
15
|
Papagiannis D, Rachiotis G, Xanthopoulos A, Simou A, Zilidis C, Triposkiadis F. Vaccination practices and influenza in professional football players in Greece. Occup Med (Lond) 2020; 70:200-202. [PMID: 32432327 DOI: 10.1093/occmed/kqaa004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND There is limited data on vaccination practices for professional footballers globally. AIMS To record vaccination practices employed by medical staff of individual football teams of the Super League Greece, and absenteeism of footballers related to influenza illness. METHODS A brief questionnaire was distributed to chief medical officers (CMOs) of the sixteen teams of the Super League Greece. Participants were asked to report vaccines they recommended for footballers. In addition, the questionnaire included questions on new cases of influenza and absenteeism due to influenza. Descriptive statistics (absolute and relative frequencies) were used for the presentation of the results. RESULTS Overall, 87% of the CMOs recommended seasonal influenza vaccine, 62% hepatitis B vaccine and 50% pneumococcal vaccine. Fourteen CMOs (87%) reported that the occurrence of seasonal influenza in the 2016-17 northern hemisphere season ranged from one to five cases, while two medical officers (12%) reported zero workdays lost due to influenza. CONCLUSIONS Our survey shows considerable variation in vaccination practices of CMOs of the Super League Greece. The results of this survey should stimulate further evaluation of vaccination policy and influenza-related absenteeism in footballers.
Collapse
Affiliation(s)
- D Papagiannis
- General Department University of Thessaly, Larissa, Greece
| | - G Rachiotis
- Department of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece
| | - A Xanthopoulos
- Department of Cardiology, Faculty of Medicine, Larissa University General Hospital, Larissa, Thessaly, Greece
| | - A Simou
- Department of Cardiology, Faculty of Medicine, Larissa University General Hospital, Larissa, Thessaly, Greece
| | - C Zilidis
- General Department University of Thessaly, Larissa, Greece
| | - F Triposkiadis
- Department of Cardiology, Faculty of Medicine, Larissa University General Hospital, Larissa, Thessaly, Greece
| |
Collapse
|
16
|
Affiliation(s)
- Monica Duarte Muñoz
- Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany,
| | - Tim Meyer
- Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany,
| |
Collapse
|
17
|
Ledo A, Schub D, Ziller C, Enders M, Stenger T, Gärtner BC, Schmidt T, Meyer T, Sester M. Elite athletes on regular training show more pronounced induction of vaccine-specific T-cells and antibodies after tetravalent influenza vaccination than controls. Brain Behav Immun 2020; 83:135-145. [PMID: 31580932 DOI: 10.1016/j.bbi.2019.09.024] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2019] [Revised: 09/27/2019] [Accepted: 09/29/2019] [Indexed: 12/20/2022] Open
Abstract
Compliance of elite athletes with vaccination recommendations is low mainly based on concerns about side-effects and perceived poor vaccine efficacy due to continued physical training. We therefore employed seasonal influenza vaccination to investigate the effect of regular physical training on vaccine-induced cellular and humoral immunity in elite athletes and controls. Lymphocyte subpopulations and vaccine-specific T-cells were quantified and functionally characterized from 45 athletes and 25 controls before, and 1, 2 and 26 weeks after vaccination. Moreover, influenza-specific antibodies and their neutralizing function were quantified. Both groups showed a significant increase in vaccine-reactive CD4 T-cell levels which peaked one week after vaccination (p < 0.0001). The increase was significantly more pronounced in athletes (4.1-fold) compared to controls (2.3-fold; p = 0.0007). The cytokine profile changed from multifunctional T-cells co-producing IFNγ, IL-2 and TNFα to cells with restricted cytokine expression. This change in functionality was associated with a significant increase in CTLA-4 expression (p < 0.0001), which again was more pronounced in athletes. Likewise, the increase in neutralizing antibodies was stronger in athletes (p = 0.004 for H1N1; p = 0.032 for H3N2). In conclusion, both groups mounted a strong vaccine-specific cellular and humoral immunity after standard vaccination. The more pronounced increase in specific T-cells and neutralizing antibodies indicates that high frequency and intensity of training enhance vaccine-responses in elite athletes.
Collapse
Affiliation(s)
- Alexandra Ledo
- Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
| | - David Schub
- Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
| | - Clemens Ziller
- Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany
| | - Martin Enders
- Laboratory Prof. G. Enders and Partners & Institute of Virology, Infectious Diseases and Epidemiology e.V., Stuttgart, Germany
| | - Tanja Stenger
- Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany
| | - Barbara C Gärtner
- Department of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany
| | - Tina Schmidt
- Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
| | - Tim Meyer
- Institute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany
| | - Martina Sester
- Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
| |
Collapse
|
18
|
Kim DS, Lee YH, Bae KS, Baek GH, Lee SY, Shim H, On MG, Rhie SJY. PyeongChang 2018 Winter Olympic Games and athletes' usage of 'polyclinic' medical services. BMJ Open Sport Exerc Med 2019; 5:e000548. [PMID: 31548900 PMCID: PMC6733333 DOI: 10.1136/bmjsem-2019-000548] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/16/2019] [Indexed: 11/03/2022] Open
Abstract
Objective This paper aims to describe the medical service of two polyclinics of the PyeongChang Winter Olympic Games and to analyse the injury and illness of athletes who visited the polyclinics during the oilympic period in order to provide some insight with respect to the future construction and operation of polyclinics in mass gathering events such as the Olympic Games. Methods The PyeongChang Olympic Village was located near the Olympic Stadium for snow sports athletes and the Gangneung Olympic Village was located near the ice venues for ice sports athletes. During the Olympic Games, polyclinics were consisted of emergency service and outpatient clinics. We retrospectively analysed the electronic medical record data of athletes who visiting polyclinics between 9 February 2018 and 25 February 2018. Results During the Olympics, there were 1639 athlete encounters in both polyclinics. Among those, injuries of athletes were 237 (14% of all athlete encounters) in total, and the most common injured site was knee joint. Upper respiratory infection was the most frequent case in diseases of athlete encounters. Total 223 cases of image study were done, MRI was 44 cases. Conclusion The PyeongChang Winter Olympic Games had the highest number of participants in the history of Winter Olympic Games. Overall 48% of athletes encountered polyclinics due to disease during the Games period. Upper respiratory infection and other seasonal diseases were more frequent this Olympic Games than before. Polyclinics were managed healthcare of athletes as well as injury and illness of athletes. In winter sports, a polyclinic and similar medical facilities should be prepare for diseases considering geography, weather as well as injuries and endemic diseases when planning future mass gathering events.
Collapse
Affiliation(s)
- Doo-Sup Kim
- Orthopaedic Surgery, Wonju College of Medicine, Yonsei University, Wonju, Republic of Korea.,Yonsei Institute of Sports Science and Exercise Medicine (YISSEM), Wonju, Republic of Korea
| | - Young-Hee Lee
- Yonsei Institute of Sports Science and Exercise Medicine (YISSEM), Wonju, Republic of Korea.,Rehabilitation Medicine, Wonju College of Medicine, Yonsei University, Wonju, Republic of Korea
| | - Keum Seok Bae
- Surgery, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.,Trauma Center, Wonju Severance Christian Hospital, Wonju, Republic of Korea
| | - Goo Hyun Baek
- Orthopedic Surgery, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea
| | - Sae Yong Lee
- Yonsei Institute of Sports Science and Exercise Medicine (YISSEM), Wonju, Republic of Korea.,Physical Education, Yonsei University, Seoul, Republic of Korea
| | - Hongjin Shim
- Surgery, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.,Trauma Center, Wonju Severance Christian Hospital, Wonju, Republic of Korea
| | - Myoung Gi On
- Orthopaedic Surgery, Wonju College of Medicine, Yonsei University, Wonju, Republic of Korea.,Yonsei Institute of Sports Science and Exercise Medicine (YISSEM), Wonju, Republic of Korea
| | - Sandy Jeong Yeon Rhie
- Yonsei Institute of Sports Science and Exercise Medicine (YISSEM), Wonju, Republic of Korea.,College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea
| |
Collapse
|
19
|
Abstract
Context: Immunizations are a cornerstone of preventive care and an important
consideration for team physicians caring for athletes. Evidence Acquisition: A PubMed search was performed from August 2016 through May 2017 as well as a
website review of the Centers for Disease Control and Prevention, World
Health Organization, and Immunization Action Coalition. Study Design: Clinical review. Level of Evidence: Level 4. Results: By keeping abreast of diseases endemic to nations to which athletes may be
traveling as well as the vaccination status of the athletes, team physicians
can provide appropriate advice regarding immunization and prevention of
disease. Conclusion: There are a host of regularly updated reliable websites to assist the team
physician in these recommendations.
Collapse
|
20
|
Antibody Response to Trivalent Influenza Vaccine in the Northern and the Southern Hemisphere in Elite Athletes. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2018. [PMID: 29876868 DOI: 10.1007/5584_2018_223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register]
Abstract
Being frequent travelers, the elite athletes are advised to undergo an influenza vaccination. The aim of the study was to describe the antibody response to repeated trivalent, inactivated, split influenza vaccine, of different antigenic content, recommended for the Northern and the Southern Hemisphere, administered to sportsmen before the Olympic Games in Brasil in 2016. Fourteen athletes were included in the study. For both A/California/7/209/pdm09 A/H1N1/ antigen and A/Switzerland/971593/2013/A/H3N2/ antigen, higher seroconversion rates were obtained after the first than the second vaccination (10.2 vs. 1.5 and 10.6 vs. 3.0, respectively; p < 0.05 both). Conversion rates for B/Phuket/3073/2013, B/Brisbane/60/2008, and A/HongKong/4801/2014/A/H3N2/ antigens were lower. Nonetheless, the protection rate was greater than 70% for all antigens contained in both vaccines. The proportion of individuals demonstrating a high level of both protection rate and response rate was greater after the first than the second vaccination. We conclude that the immunological response after influenza vaccination is good in elite athletes and remains so after a second influenza vaccination required due to a different vaccine composition recommended for different hemispheres.
Collapse
|
21
|
Conway JJ, Toresdahl BG, Ling DI, Boniquit NT, Callahan LR, Kinderknecht JJ. Prevalence of Inadequate Immunity to Measles, Mumps, Rubella, and Varicella in MLB and NBA Athletes. Sports Health 2018; 10:406-411. [PMID: 29792776 PMCID: PMC6116110 DOI: 10.1177/1941738118777726] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND Multiple outbreaks of vaccine-preventable viral diseases have occurred in professional sports in recent years. Currently, there is no established protocol for vaccination or immunity screening for professional athletes. HYPOTHESIS There are significant differences in the prevalence of inadequate immunity dependent on age, sport, country of birth, and participation in collegiate sports. STUDY DESIGN Cross-sectional cohort study. LEVEL OF EVIDENCE Level 4. METHODS A sample of Major League Baseball (MLB) and National Basketball Association (NBA) players were screened for serologic evidence of immunity to measles, mumps, rubella, and varicella prior to the 2015 and 2016 seasons. The results were designated as adequate (immune) or inadequate (equivocal or nonimmune) based on laboratory criteria. Comparison with an age-matched control group was performed using data from the National Health and Nutrition Examination Survey (NHANES). RESULTS A total of 98 athletes (62 MLB, 36 NBA) were screened. The prevalence of inadequate immunity for any virus was 35.5% in MLB players and 33.3% in NBA players. There was a significantly greater risk of inadequate immunity to rubella (risk ratio, 6.38; P < 0.01) and varicella (risk ratio, 4.21; P < 0.01) in athletes compared with the age-matched NHANES population. Our analysis did not reveal differences in rates of immunity based on sport, country of birth (US born vs international), or participation in college athletics. There was a lower rate of inadequate immunity to varicella with increasing age (odds ratio, 0.72; P = 0.05). CONCLUSION One-third of athletes studied had inadequate immunity to 1 of the 4 viruses tested. Younger players had a significantly greater risk of inadequate immunity to varicella. Birth outside the US and lack of participation in college athletics were not found to influence immunity rates. CLINICAL RELEVANCE These results can inform the development of future screening programs to prevent outbreaks of viral infections in professional athletes.
Collapse
|
22
|
Tafuri S, Sinesi D, Gallone MS. Vaccinations among athletes: evidence and recommendations. Expert Rev Vaccines 2017; 16:867-869. [DOI: 10.1080/14760584.2017.1358092] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- Silvio Tafuri
- Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy
| | - Domenico Sinesi
- Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy
| | - Maria Serena Gallone
- Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy
| |
Collapse
|
23
|
Vancini RL, Andrade MS, Vancini-Campanharo CR, de Lira CAB. Yellow Fever and Traveling Athletes: Is Competing in Brazil Safe? J Hum Kinet 2017; 57:5-6. [PMID: 28713453 PMCID: PMC5504573 DOI: 10.1515/hukin-2017-0041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Affiliation(s)
- Rodrigo Luiz Vancini
- Centro de Educação Física e Desportos (CEFD), Universidade Federal do Espírito Santo (UFES), Espírito Santo (ES), Brasil; CEFD/UFES, Campus Universitário: Av. Fernando Ferrari, 514, Goiabeiras, Vitória (ES), CEP: 29075810, Brazil
| | - Marília Santos Andrade
- Departamento de Fisiologia, Universidade Federal de Säo Paulo (UNIFESP), São Paulo (SP), Brasil; Departamento de Fisiologia/UNIFESP: Rua Botucatu, 862, 5º andar, Ed. Ciências Biomédicas, Vila Clementino, São Paulo (SP), CEP: 04023-900, Brazil
| | - Cássia Regina Vancini-Campanharo
- Escola Paulista de Enfermagem, Universidade Federal de São Paulo (UNIFESP), São Paulo (SP), Brasil; Escola Paulista de Enfermagem - UNIFESP: Rua Napoleão de Barros, 754, 2º andar, São Paulo (SP), CEP: 04024-002, Brazil
| | - Claudio Andre Barbosa de Lira
- Setor de Fisiologia Humana e do Exercício, Faculdade de Educação Física e Dança, Universidade Federal de Goiás (UFG), Goiânia (GO), Brasil; Faculdade de Educação Física e Dança - UFG: Avenida Esperança s/n, Campus Samambaia, Goiânia (GO), CEP: 74690-900, Brasil
| |
Collapse
|
24
|
Pertussis outbreak in Polish shooters with adverse event analysis. Biol Sport 2017; 34:243-248. [PMID: 29158617 PMCID: PMC5676320 DOI: 10.5114/biolsport.2017.66001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2016] [Revised: 12/06/2016] [Accepted: 01/20/2017] [Indexed: 12/13/2022] Open
Abstract
In addition to different injuries, infections are the most common reason for giving up training altogether or reducing its volume and intensity, as well as a lack of opportunities to participate in sports competitions. Nowadays, a slow but constant re-emergence of pertussis, especially among teenagers and young adults, including athletes, can be observed. This paper describes an outbreak of pertussis among professional Polish shooters, focusing on the transmission of Bordetella pertussis infection between members of the national team, its influence on performance capacity and adverse event analysis. From 9 June, 2015 to 31 July, 2015, a total of 4 confirmed and suspected cases of pertussis were reported among members of the Polish Sport Shooting National Team, their relatives and acquaintances. Pertussis significantly decreased exercise performance of the first athlete, a 35-year-old woman, interrupted her training, and finally resulted in failure to win a medal or quota place. Pertussis also significantly decreased performance of the second athlete, a 25-year-old shooter. The other cases emerged in their families. Whooping cough is a real threat to athletes and should be prevented. Preventive measures include appropriate immunization, constant medical supervision, as well as early isolation, diagnostic tests and treatment of all infected sport team members. Regular administration of booster doses of the acellular pertussis vaccine (Tdpa) every 5 years seems reasonable.
Collapse
|
25
|
Abstract
Although the medical complications of sports are usually traumatic in nature, infectious hazards also arise. While blood-borne pathogens such as HIV, hepatitis B, and hepatitis C, cause significant illness, the risk of acquiring these agents during sporting activities is minimal. Skin infections are more commonplace, arising from a variety of microbial agents including bacterial, fungal, and viral pathogens. Sports involving water contact can lead to enteric infections, eye infections, or disseminated infections such as leptospirosis. Mumps, measles, and influenza are vaccine-preventable diseases that have been transmitted during sporting events, both in players and in spectators. Prevention is the key to many of these infections. Players should be vaccinated and should not participate in sports if their infection can be spread by contact, airborne, or droplet transmission.
Collapse
|
26
|
Vaccination in Elite Athletes: A Call to Action to Develop Guidelines for All Infectious Diseases. Sports Med 2014; 45:447-8. [DOI: 10.1007/s40279-014-0290-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|